An advisory board of renowned experts in oncology and patient engagement is actively engaged in survey assessment for relevance to real-world issues and will be reviewing and interpreting the survey data. The members of the advisory board follow:

Walter Baile, MD: Professor, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences; Director, Program for Interpersonal Communication And Relationship Enhancement (I*CARE), The University of Texas MD Anderson Cancer Center, Houston

Ethan Basch, MD, MSc: Director, Cancer Outcomes Research Program; Associate Professor, Medicine and Public Health, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Jimmie Holland, MD: Wayne E. Chapman Chair in Psychiatric Oncology, Memorial Sloan Kettering Cancer Center, New York

Marcia Kean, MBA: Chairman, Strategic Initiatives, Feinstein Kean Healthcare, Cambridge, Massachusetts

Sandra Kurtin, RN, MSN, AOCN, ANP-C, Adjunct Associate Professor, The University of Arizona Cancer Center, Tucson

Terry Langbaum, MHS: Chief Administrative Officer, Johns Hopkins Kimmel Cancer Center, Baltimore

Renee Nicholas: Associate Vice President, Business Development, Entertainment Industry Foundation

Michael Parisi, MBA: President, CancerCare Board of Trustees, and Managing Partner, Ogilvy CommonHealth Worldwide, New York

Lee Schwartzberg, MD, FACP: Chief, Division of Hematology Oncology, The University of Tennessee Health Science Center, and Medical Director, The West Clinic, Memphis

Michael K. Wong, MD, PhD, FRCPC: Berle and Lucy Adams Chair in Cancer Research, Professor of Clinical Medicine, and Section Chief, Solid Tumor, USC Norris Comprehensive Cancer Center, Los Angeles

Thomas Workman, PhD: Principal Communication Researcher and Evaluator, American Institutes for Research, Washington, DC

Patricia Goldsmith: Chief Executive Officer, CancerCare, New York

Ellen Sonet, MBA, JD: Chief Strategy and Alliance Officer, CancerCare, New York